<DOC>
	<DOCNO>NCT01510782</DOCNO>
	<brief_summary>To investigate safety tolerability BI 655064 healthy male volunteer follow intravenous infusion escalate single dos follow subcutaneous injection . Exploration pharmacokinetics pharmacodynamics BI 655064 single dose determination bioavailability subcutaneous injection BI 655064 .</brief_summary>
	<brief_title>Single Rising Dose Study ( Intravenous Infusion Subcutaneous Injection ) BI 655064 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : 1 . Healthy male subject Exclusion criterion : 1 . Any relevant deviation healthy condition</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>